Federal Contractor Profile
Lovelace Biomedical Research Institute
$39.9M obligated·83 awards·5 agencies·9 NAICS
Federal Contracts
Showing contracts 51–69 of 69 total. Sorted by action date, most recent first. Excludes $0 modifications.
| Date | Agency | PIID | NAICS | Description | Amount |
|---|---|---|---|---|---|
| Sep 20, 2022 | Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NIDA | 75N95022F00002 | 541715 | ASSESSMENT OF POTENTIAL TREATMENTS FOR DRUG-INDUCED RESPIRATORY DEPRESSION AND OVERDOSE TOXICITY. POP: SEPTEMBER 26, 2022 - MARCH 25, 2023. TASK ORDER 75N95022F00002 (TO2). | $163K |
| Sep 20, 2022 | Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NIDA | 75N95022F00001 | 541715 | ASSESSMENT OF POTENTIAL TREATMENTS FOR DRUG-INDUCED RESPIRATORY DEPRESSION AND OVERDOSE TOXICITY. POP: SEPTEMBER 26, 2022 - MARCH 25, 2023. TASK ORDER 75N95022F00001 (TO1). | $149K |
| Sep 16, 2022 | Department of DefenseW4PZ USA MED RSCH ACQUIS ACT | W81XWH22P0157 | 511210 | LICENSE AND MAINTENANCE SUPPORT, ON-SITE SUPPORT SERVICES FOR VSP WRAIR. | $212K |
| Sep 14, 2022 | Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NHLBI | 75N92022F00250 | 561320 | NIH/NHBLI/PSB LAB RESEARCHER REQUIRES MOUSE STUDY OF SMOKING REQUIRED IN ORDER TO TO FOLLOW UP ON RESEARCH AIMS OF LEVY LAB AND CONTINUE DEVELOPING THERAPEUTIC TARGET. [22-018080] | $25K |
| Sep 9, 2022 | Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NHLBI | 75N92022F00001 | 541714 | GENE THERAPY RESOURCE PROGRAM (GTRP): PHARMACOLOGY AND TOXICOLOGY CORE LABORATORY | $1.3M |
| Aug 31, 2022 | Department of DefenseDEFENSE HEALTH AGENCY | HT001122F0101 | 541714 | MILITARY MEDICAL RESEARCH AND DEVELOPMENT SERVICES | $3K |
| Aug 31, 2022 | Department of Health and Human ServicesBARDA - ASPR / DAAPPO / BARDA DCMA | 75A50122D00013 | 541714 | LOVELACE BIOMEDICAL RESEARCH INSTITUTE (RADNUC) - IDIQ FOR BARDA CRN ANIMAL MODEL DEVELOPMENT | $75K |
| Jul 27, 2022 | Department of Health and Human ServicesBARDA - ASPR / DAAPPO / BARDA DCMA | 75A50122D00008 | 541714 | LOVELACE BIOMEDICAL RESEARCH INSTITUTE(CHEM) - IDIQ FOR BARDA CRN ANIMAL MODEL DEVELOPMENT | $75K |
| Jul 22, 2022 | Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NIDA | 75N95019F00088 | 541715 | DISEASE MODEL CHARACTERIZATION AND DEVELOPMENT OF ASSAYS TO EVALUATE AND MEASURE PAIN IN A PORCINE MODEL FOR SICKLE CELL DISEASE (SCD) | $675K |
| Jun 23, 2022 | Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NIDA | 75N95019D00030 | 541715 | CRO SUPPORT FOR NCATS MEDICINAL CHEMISTRY FOR LEAD OPTIMIZATION. | $4K |
| Jun 16, 2022 | Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NIDA | 75N95022F00001 | 541715 | BIOANALYTICAL SUPPORTS FOR A GLP TOX/BIODISTRIBUTION STUDY IN MINI-PIGS | $748K |
| Jun 13, 2022 | Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NIDA | 75N95020F00005 | 541715 | EFFICACY AND SAFETY EVALUATION OF A LEAD GENE THERAPY CANDIDATE IN PROPIONIC ACIDEMIA (PA) DISEASE MOUSE MODELS AND BIOANALYTICAL ASSAY METHODS DEVELOPMENT. PERIOD OF PERFORMANCE SEPTEMBER 25, 2020 - SEPTEMBER 24, 2022 | $172K |
| May 11, 2022 | Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NIDA | 75N95021F00001 | 541715 | CHARACTERIZATION OF A NON-PARALYZING BONT-BASED BIOPHARMACEUTICAL FOR THE TREATMENT OF NEUROPATHIC PAIN | $71K |
| Apr 6, 2022 | Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NIDA | 75N95020F00002 | 541715 | CHARACTERIZATION OF A NON-ADDICTIVE SMALL MOLECULE THERAPEUTICS FOR THE MANAGEMENT OF NON-CANCER PAIN PERIOD OF PERFORMANCE SEPTEMBER 18, 2020 - SEPTEMBER 17, 2022 | $370K |
| Apr 6, 2022 | Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NIDA | 75N95019F00088 | 541715 | DISEASE MODEL CHARACTERIZATION AND DEVELOPMENT OF ASSAYS TO EVALUATE AND MEASURE PAIN IN A PORCINE MODEL FOR SICKLE CELL DISEASE (SCD) | $227K |
| Nov 12, 2021 | Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NIAID | 75N93022F00001 | 541715 | THE CONTRACTOR SHALL PERFORM THE TRANSFER, VALIDATION AND QUALIFICATION OF BIOANALYTICAL METHODS FOR DETECTION OF CABOTEGRAVIR AND LEVONORGESTREL IN RAT AND NONHUMAN PRIMATE PLASMA | $486K |
| Aug 31, 2021 | Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NIAID | 75N93021F00001 | 541714 | COMPREHENSIVE AND RAPID RESPONSE FOR NIAID RESEARCH PROGRAMS | $2K |
| Aug 23, 2021 | Department of DefenseW4PZ USA MED RSCH ACQUIS ACT | W81XWH17C0235 | 511210 | IGF::OT::IGF ANIMAL MANAGEMENT SYSTEM SOFTWARE LICENSE/SUPPORT | $202K |
| Jun 15, 2021 | Department of DefenseFA9451 AFRL RDK | FA945120P0019 | 541380 | COVID-19 THE PURPOSE OF VIDER IS TO UNDERSTAND THE EFFECTIVENESS OF RF DIRECTED ENERGY RADIATION IN REDUCING THE VIABILITY OF VIRAL AEROSOLS WITH THE GOAL OF RAPIDLY DEVELOPING AND DEPLOYING REMEDIATION METHODS FOR SPACES CONTAMINATED WITH SARS-COV-2 | $100K |
Get Alerted Before Lovelace Biomedical Research Institute's Next Recompete
Mindy monitors active contracts and flags recompetes 12 months out so you can position to compete.
Start Free